相关实验视频

Updated: Jun 10, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

新兴的创新治疗策略对于晚期清细胞细胞癌的治疗

Sharon H Choi¹, Yu-Wei Chen¹, Justine Panian¹

¹Division of Hematology Oncology, University of California San Diego, San Diego, CA, United States.

|October 14, 2024

概括

了解希佩尔·林道 (VHL) 基因和免疫检查点的进步已经改变了转移性细胞癌 (RCC) 治疗,改善了患者的生存率. 目前正在进行的研究旨在进一步优化这种致命癌症的治疗方法.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
免疫学免疫学免疫学

背景情况:

自20世纪90年代以来,转移性细胞癌 (RCC) 治疗发生了显著的进化.
·希佩尔·林多 (VHL) 基因变异通过亲血管性途径驱动清细胞RCC (ccRCC) 病原体.
针对VHL/HIF/VEGF轴的抗血管生成疗法改善了转移性ccRCC的存活率.

研究的目的:

审查改变转移性RCC理解和治疗的关键发现.
突出新和发展转移性RCC的治疗策略.
强调需要在RCC治疗中继续取得进展.

主要方法:

对转移性RCC的重大生物发现和临床发现的审查.
对抗血管新生和免疫检查点抑制剂疗法的影响分析.
检查当前和新兴的治疗策略.

主要成果:

VHL基因的改变是ccRCC的核心,并被抗血管原性疗法所准.
免疫检查点抑制剂,特别是在组合中,代表了对RCC的治疗新标准.
这些进展导致了持久的反应和改善的临床结果.

结论:

对VHL/HIF/VEGF和免疫检查点的理解已经彻底改变了转移性RCC治疗.
尽管取得了进展,但高死亡率需要进一步研究和优化治疗方案.
新的治疗策略正在开发中,以解决转移性RCC管理中的未满足需求.

关键词:

这是一种抗angiogenic的药物.免疫检查点抑制剂免疫检查点抑制剂细胞癌瘤是细胞癌.治疗选择治疗选择

更多相关视频

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...